Catabolism of glycoconjugates in chronic otitis media with cholesteatoma

Journal of Investigative Medicine

Volumn 55, Issue 5, 2007, Pages 248-254

  Olszewska, Ewa ^a   Borzym Kluczyk, Malgorzata ^a   Olszewski, Slawomir ^a   Zwierz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Catabolism of glycoconjugates; Cholesteatoma; Normal postauricular skin; mannosidase; galactosidase

Indexed keywords

4 NITROPHENOL; ALPHA MANNOSIDASE; BETA GALACTOSIDASE; GLYCOCONJUGATE; GLYCOLIPID; GLYCOPROTEIN; PROTEOGLYCAN;

ADULT; AGED; ARTICLE; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOLYSIS; PROTEIN DEGRADATION;

EID: 35048832859     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2007.00005     Document Type: Article

References (36)

1. Schönermark M, Mester B, Kempf H-G, et al. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol (Stockh) 1996;116:451-6.
2. Chole RA. The molecular biology of bone resorption due to chronic otitis media. Ann N Y Acad Sci 1997;830:95-109.
3. Olszewska E, Wagner M, Bernal-Sprekelsen M, et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 2004;261:6-24.
4. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-42.
5. Jung JY, Chole RA. Bone resorption in chronic otitis media: the role of the osteoclasts. ORL J Otorhinolaryngol Relat Spec 2002;64:95-107.
6. Hasilik A, Neufeld EF. Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. J Biol Chem 1980;255:4937-45.
7. Chambers TJ, Darby JA, Fuller K. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res 1985;241:671-5.
8. Popko J, Marciniak J, Zalewska A, et al. The activity of exoglycosidases in the synovial membrane and knee fluid of patients with rheumatoid arthritis and juvenile idiopathic arthritis. Scand J Rheumatol 2006;35:189-92.
9. Aronson NNJ, Kuranda MJ. Lysosomal degradation of Asn-linked glycoproteins. FASEB J 1989;3:2615-22.
10. Carroll M, Dance N, Masson PK, et al. Human mannosidosis - the enzyme defect. Biochem Biophys Res Commun 1972;49:579-83.
11. Shipkowski S, Brenchley JE. Characterization of an unusual cold-active β-glucosidase belonging to family 3 of the glycoside hydrolases from the psychrophilic isolate Paenibacillus sp. strain C7. Appl Environ Microbiol 2005; 71:4225-32.
12. Krishna DR, Sperker B, Fritz P, Klotz U. Does pH 6 beta-galactosidase activity indicate cell senescence? Mech Ageing Dev 1999;109:113-23.
13. Tanaka H, Meisler M, Suzuki K. Activity of human hepatic beta-galactosidase toward natural glycosphingolipid substrates. Biochim Biophys Acta 1975;398:452-63.
14. Lerner U, Hanstrom L. Influence of diphenylhydantoin on lysosomal enzyme release during bone resorption in vitro. Acta Pharmacol Toxicol 1980;47:144-50.
15. Thamotharan M, Lombardo YB, Bawani SZ, Adibi SA. An active mechanism for completion of the final stage of protein degradation in the liver, lysosomal transport of dipeptides. J Biol Chem 1997;272:11786-90.
16. Chole RA, Hughes RM, Faddis BT. Keratin particle-induced osteolysis: a mouse model of inflammatory bone remodeling related to cholesteatoma. J Assoc Res Otolaryngol 2001;2:65-71.
17. Tos M. Manual of middle ear surgery. Stuttgart: Thieme; 1988.
18. Chatterjee S, Velicer LF, Sweeley CC. Glycosphingolipid glycosyl hydrolases and glycosidases of synchronized human KB cells. J Biol Chem 1975;250:4972-9.
19. Zwierz K, Gindzienski A, Glowacka D, Porowski T. The degradation of glycoconjugates in the human gastric mucous membrane. Acta Med Acad Sci Hung 1981;38:145-52.
20. Moriyama H, Honda Y, Huang CC, et al. Bone resorption in cholesteatoma: epithelial-mesenchymal cell interaction collagenase production. Laryngoscope 1987;97:854-9.
21. Ahn JM, Huang CC, Abramson M. Interleukin-1 causing bone destruction in middle ear cholesteatoma. Otolaryngol Head Neck Surg 1990;103:527-36.
22. Schultz P, Bujia J, Holly A, et al. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otol 1993;14:82-7.
23. Marenda SA, Aufdemorte TB. Localization of cytokines in cholesteatoma tissue. Otolaryngol Head Neck Surg 1995; 113:359-68.
24. Iino Y, Toriyama M, Sugawa I, Mori S. Relationship between keratin and lymphocytes in granulation tissue in cholesteatoma otitis. Pract Otol (Kyoto) 1988;81:581-6.
25. Iino Y, Toriyama M, Ohmi S, Kanegasaki S. Activation of peritoneal macrophages with human cholesteatoma debris and α-keratin. Acta Otolaryngol (Stockh) 1990;109:444-9.
26. Wielgat P, Pancewicz S, Hermanowicz-Szpakowicz T, et al. [Activity of lysosomal exoglycosidases in serum of patients with chronic Borrelia arthritis]. Przegl Epidemiol 2004;58:451-8.
27. Olszewska E, Borzym-Kluczyk M, Olszewski S, et al. Hexosaminidase as a new potential marker for middle ear cholesteatoma. Clin Biochem 2006;39:1088-90.
28. Chodynicki S, Chyczewski L, Olszewska E. Imunohistochemical investigation of cathepsin D activity in structures of cholesteatoma. Med Sci Monit 2002;8:BR184-6.
29. Yoshikawa M, Kojima H, Wada K, et al. Identification of specific gene expression profiles in fibroblast derived from middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 2006;132:734-42.
30. Bazzi C, Petrini C, Rizza V, et al. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890-6.
31. Popko J, Zalewska A, Golaszewska Z, et al. Comparative analysis of hexosaminidase and cathepsin D expression in synovial fluid of patients with rheumatoid arthritis and traumatized joints. Clin Exp Rheumatol 2005;23:725-6.
32. Popko J, Zalewska A, Olszewski S, et al. Activity of N-acetyl-β- hexosaminidase in serum and joint fluid of the knees of patients with juvenile idiopatic arthritis. Clin Exp Rheumatol 2003;21:675.
33. Liu J, Numa MM, Liu H, et al. Synthesis and high-throughput screening of N-acetyl-beta-hexosaminidase inhibitor libraries targeting osteoarthritis. J Org Chem 2004;69:6273-83.
34. Lee JK, Chae SW, Cho JG, et al. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 2006;263:1077-81.
35. Huisman MA, De Heer E, Grote JJ. Terminal differentiation and mitogen-activated protein kinase signaling in human cholesteatoma epithelium. Otol Neurotol 2006;27:422-6.
36. Yetiser S, Satar B, Aydin N. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma. Otol Neurotol 2002;23:647-52.